Integrative proteogenomic, transcriptomic and structural prioritization of therapeutic targets for anorexia nervosa
Background Anorexia nervosa (AN) lacks an approved pharmacotherapy for its core psychopathology. We aimed to prioritize genetically supported and therapeutically tractable molecular targets. Methods Cis-pQTL instruments were evaluated against the 2017 and 2019 AN GWAS datasets using drug-target Mendelian randomization and Bayesian colocalization. Eight core targets were subsequently examined using sensitivity analyses, pQTL- and eQTL-based SMR/HEIDI, eQTLGen blood data, GTEx v10 brain tissues, pleiotropy annotation, enrichment analysis, protein-interaction networks, druggability annotation and exploratory molecular docking. Results NCAM1 showed the most coherent protein-level evidence, with directionally concordant nominal IVW associations in both AN GWAS datasets and global PP.H4 = 0.726 in PGC2017. CRIM1 showed the most reproducible nominal transcript-level pattern across blood SMR and cerebellar GTEx MR analyses, although neither blood nor brain transcript-level colocalization provided strong evidence for a shared causal variant. CALCA received the highest translational annotation score because of established CGRP-pathway pharmacology; this
Authors
- Yao Bi (ORCID: https://orcid.org/0009-0007-9887-6770)
- Xiangyun Yang (ORCID: https://orcid.org/0000-0002-8610-4120)
- Zhan-Jiang Li
- Peng-Chong Wang
- Xu Lin
Institutions
- Beijing Anding Hospital (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-11520215/v1
- Primary Topic
- Eating Disorders and Behaviors
- Type
- preprint